🔎 Trials Near Me

Utama › Obesiti › Texas › The Woodlands

Kajian klinikal Obesiti di The Woodlands, TX

12 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar The Woodlands (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Mengambil pesertaFasa 2
  • Texas Cardiology Associates of Houston, Kingwood · 20 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07783802

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Mengambil pesertaFasa 3
  • Martin Diagnostic Clinic, Tomball · 9 mi jauh
Umur 6 hingga 17 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Mengambil pesertaFasa 3
  • Activian Clinical Research, Kingwood · 20 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07392190

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Mengambil pesertaFasa 3
  • Tcr Institute Llc, Kingwood · 20 mi jauh
Umur 45 hingga 99 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07037433

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Mengambil pesertaFasa 3
  • AURORA-1 Clinical Site, Tomball · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Mengambil pesertaFasa 3
  • AURORA-2 Clinical Site, Tomball · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Mengambil pesertaFasa 3
  • Northwest Houston Clinical Research PLLC, Tomball · 9 mi jauh
  • Javara Research, Conroe · 11 mi jauh
Umur 18 hingga 99 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Mengambil pesertaFasa 3
  • DM Clinical Research, Tomball · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07351058

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Mengambil pesertaFasa 3
  • Kailera Clinical Site, Tomball · 9 mi jauh
  • Kailera Clinical Site, Kingwood · 20 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Mengambil pesertaFasa 3
  • Kailera Clinical Site, Tomball · 9 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07284875

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Mengambil pesertaFasa 3
  • Northwest Houston Heart Center, Tomball · 9 mi jauh
Umur 18 hingga 99 · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Mengambil pesertaFasa 3
  • Javara Inc. / Privia Medical Group Gulf Coast PLLC, Conroe · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07567001

Kajian Obesiti di bandar lain

Kajian lain di The Woodlands

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.